Clinical Trial Update: Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating creatine as treatment for female adolescents with major depressive disorder who did not respond to fluoxetine or escitalopram;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: University of Utah | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2015-01-13